AstraZeneca PLC (AZNCF)
135.05
-1.10
(-0.81%)
USD |
OTCM |
Sep 29, 16:00
AstraZeneca Price to Book Value: 5.598 for Sept. 29, 2023
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 29, 2023 | 5.598 |
| September 28, 2023 | 5.643 |
| September 27, 2023 | 5.520 |
| September 26, 2023 | 5.594 |
| September 25, 2023 | 5.678 |
| September 22, 2023 | 5.717 |
| September 21, 2023 | 5.552 |
| September 20, 2023 | 5.651 |
| September 19, 2023 | 5.416 |
| September 18, 2023 | 5.449 |
| September 15, 2023 | 5.732 |
| September 14, 2023 | 5.513 |
| September 13, 2023 | 5.392 |
| September 12, 2023 | 5.481 |
| September 11, 2023 | 5.625 |
| September 08, 2023 | 5.625 |
| September 07, 2023 | 5.582 |
| September 06, 2023 | 5.550 |
| September 05, 2023 | 5.550 |
| September 01, 2023 | 5.637 |
| August 31, 2023 | 5.556 |
| August 30, 2023 | 5.667 |
| August 29, 2023 | 5.766 |
| August 28, 2023 | 5.664 |
| August 25, 2023 | 5.636 |
| Date | Value |
|---|---|
| August 24, 2023 | 5.637 |
| August 23, 2023 | 5.776 |
| August 22, 2023 | 5.629 |
| August 21, 2023 | 5.676 |
| August 18, 2023 | 5.638 |
| August 17, 2023 | 5.698 |
| August 16, 2023 | 5.702 |
| August 15, 2023 | 5.702 |
| August 14, 2023 | 5.936 |
| August 11, 2023 | 5.866 |
| August 10, 2023 | 5.718 |
| August 09, 2023 | 5.859 |
| August 08, 2023 | 5.859 |
| August 07, 2023 | 5.856 |
| August 04, 2023 | 5.813 |
| August 03, 2023 | 5.762 |
| August 02, 2023 | 5.767 |
| August 01, 2023 | 5.921 |
| July 31, 2023 | 6.003 |
| July 28, 2023 | 5.838 |
| July 27, 2023 | 5.822 |
| July 26, 2023 | 5.824 |
| July 25, 2023 | 5.683 |
| July 24, 2023 | 5.773 |
| July 21, 2023 | 5.675 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.182
Minimum
Dec 13 2021
13.56
Maximum
May 21 2020
8.126
Average
8.290
Median
Sep 16 2019
Price to Book Value Benchmarks
| GSK PLC | 4.637 |
| Adaptimmune Therapeutics PLC | 1.396 |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals Plc | 0.3085 |
Price to Book Value Related Metrics
| PE Ratio | 34.10 |
| PS Ratio | 4.735 |
| Price to Free Cash Flow | 32.11 |
| Price | 135.05 |
| Earnings Yield | 2.93% |
| Market Cap | 209.31B |
| Operating PE Ratio | 32.40 |
| Normalized PE Ratio | 37.51 |